Table 6.
SF-8 scores of the subgroup who underwent recurrence treatment before treatment and at 1, 3, and 6 months after BAE and comparisons of the pre-treatment scores and those at 1, 3, and 6 months after BAE
| Total, n = 24 | SF-8 mean (SD) | p | |||||
|---|---|---|---|---|---|---|---|
| Before treatment | 1 month after BAE | 3 months after BAE | 6 months after BAE | Before vs. 1 month after BAE | Before vs. 3 months after BAE | Before vs. 6 months after BAE | |
| Physical component score | 40.40 (8.89) | 45.50 (5.60) | 43.74 (8.16) | 43.70 (8.43) | 0.040 | 0.193 | 0.082 |
| Physical functioning | 37.66 (10.87) | 43.48 (7.89) | 41.10 (10.86) | 42.50 (9.25) | 0.035 | 0.498 | 0.027 |
| Role physical | 39.60 (11.77) | 43.49 (8.23) | 42.61 (10.43) | 39.40 (10.80) | 0.121 | 0.759 | 0.722 |
| Bodily pain | 47.79 (10.07) | 51.28 (8.30) | 51.77 (7.35) | 51.57 (8.22) | 0.130 | 0.128 | 0.087 |
| General health | 43.85 (6.72) | 48.32 (6.69) | 48.36 (8.13) | 46.07 (9.45) | 0.068 | 0.288 | 0.342 |
| Mental component score | 43.38 (8.82) | 44.36 (7.75) | 46.27 (8.84) | 43.85 (9.74) | 0.970 | 0.981 | 0.961 |
| Vitality | 44.59 (8.28) | 47.87 (6.22) | 46.93 (7.75) | 47.68 (8.18) | 0.190 | 0.904 | 0.253 |
| Social functioning | 40.16 (11.45) | 41.28 (10.28) | 42.80 (12.39) | 40.27 (10.96) | 0.724 | 0.833 | 0.858 |
| Role emotional | 41.15 (11.48) | 43.53 (9.08) | 44.09 (10.33) | 43.80 (9.13) | 0.246 | 0.203 | 0.089 |
| Mental health | 44.41 (9.07) | 47.12 (8.08) | 48.62 (8.71) | 45.05 (10.15) | 0.513 | 0.372 | 0.733 |
BAE, bronchial artery embolisation; SD, standard deviation